BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3912041)

  • 1. Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus.
    Sternberg C; Kelsen D; Dukeman M; Leichman L; Heelan R
    Cancer Treat Rep; 1985 Nov; 69(11):1305-7. PubMed ID: 3912041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of carboplatin in non-small cell lung cancer.
    Tamura T; Shinkai T; Eguchi K; Sasaki Y; Fujiwara Y; Fukuda M; Ohe Y; Nakagawa K; Minato K; Saijo N
    Jpn J Clin Oncol; 1989 Mar; 19(1):51-5. PubMed ID: 2537907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phase II study of carboplatin in head and neck cancer].
    Inuyama Y; Togawa K; Morita M; Takeoda S; Kaneko T; Takemiya S; Ono I; Nomura Y; Okuda M; Kikuchi K
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2131-8. PubMed ID: 3293536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study.
    Al-Sarraf M; Metch B; Kish J; Ensley J; Rinehart JJ; Schuller DE; Coltman CA
    Cancer Treat Rep; 1987; 71(7-8):723-6. PubMed ID: 3300967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].
    Xu RH; Shi YX; Guan ZZ; Jiang WQ; Huang H; Ma ZY; Wang JH; Hu XH; Xie WM; Li XG; Liu YL; Pan LX; Dai AD; Zhuang W; Zhang C
    Ai Zheng; 2006 Dec; 25(12):1565-8. PubMed ID: 17166388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer.
    Kelsen DP; Fein R; Coonley C; Heelan R; Bains M
    Cancer Treat Rep; 1986 Feb; 70(2):255-9. PubMed ID: 3948190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of carboplatin (CBDCA) in children with cancer.
    Bacha DM; Caparros-Sison B; Allen JA; Walker R; Tan CT
    Cancer Treat Rep; 1986 Jul; 70(7):865-9. PubMed ID: 3521846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas.
    Kato H; Fukuchi M; Manda R; Nakajima M; Miyazaki T; Sohda M; Masuda N; Fukai Y; Tsukada K; Kuwano H
    Anticancer Res; 2003; 23(4):3493-8. PubMed ID: 12926096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of carboplatin in advanced malignant melanoma.
    Evans LM; Casper ES; Rosenbluth R
    Cancer Treat Rep; 1987 Feb; 71(2):171-2. PubMed ID: 3542209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of hematologic toxicity of carboplatin by creatinine clearance rate.
    Taguchi J; Saijo N; Miura K; Shinkai T; Eguchi K; Sasaki Y; Tamura T; Sakurai M; Minato K; Fujiwara Y
    Jpn J Cancer Res; 1987 Sep; 78(9):977-82. PubMed ID: 3117753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
    Kelsen DP; Bains M; Chapman R; Golbey R
    Cancer Treat Rep; 1981; 65(9-10):781-5. PubMed ID: 6168370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
    Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
    Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
    Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma.
    Evans BD; Raju KS; Calvert AH; Harland SJ; Wiltshaw E
    Cancer Treat Rep; 1983 Nov; 67(11):997-1000. PubMed ID: 6315233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase II study of carboplatin in genitourinary cancer. Urological Cooperative Study Group on Carboplatin].
    Niijima T; Tazaki H
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2305-11. PubMed ID: 3044277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin therapy in advanced endometrial cancer.
    Green JB; Green S; Alberts DS; O'Toole R; Surwit EA; Noltimier JW
    Obstet Gynecol; 1990 Apr; 75(4):696-700. PubMed ID: 2179783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboplatin in the treatment of oesophageal cancer.
    Mannell A; Winters Z
    S Afr Med J; 1989 Sep; 76(5):213-4. PubMed ID: 2672377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study.
    Chambers SK; Davis CA; Schwartz PE; Kohorn EI; Chambers JT
    Clin Cancer Res; 1996 Oct; 2(10):1693-7. PubMed ID: 9816118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase II study of paclitaxel and cisplatin for advanced squamous-cell carcinoma of esophagus].
    Huang J; Cai RG; Meng PJ; Zhang MJ; Cui CX; Yang L; Chu DT; Sun Y; Wang JW
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):753-5. PubMed ID: 15733398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An early phase II trial combining cisplatin, carboplatin and vindesine in patients with inoperable non-small cell lung cancer].
    Haneda H; Koizumi M; Hayashi T
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):227-31. PubMed ID: 10700892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.